Immunocore Holdings Income Statement (2022-2025) | IMCR

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 54.66M59.76M64.85M70.16M70.50M75.40M80.25M84.05M93.88M97.96M103.69M
Cost of Revenue 0.22M0.35M0.28M0.20M0.25M1.71M0.45M0.33M0.83M1.04M0.51M
Gross Profit 54.44M59.41M64.57M69.96M70.26M73.69M79.80M83.72M93.05M96.92M103.18M
Operating items
Research & Development 36.57M38.16M43.25M45.56M57.46M51.07M52.77M60.85M56.47M69.01M70.57M
Selling, General & Administrative 32.57M35.01M35.47M41.45M39.29M38.64M35.53M42.32M40.20M42.79M39.78M
Operating Expenses 69.14M73.17M78.72M87.01M96.75M89.71M88.30M103.17M96.67M111.80M110.35M
Operating Income -14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M
EBIT -14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M
Non-operating items
Interest & Investment Income 3.13M4.28M5.14M5.44M8.25M6.24M5.96M5.17M4.18M4.27M4.12M
Other Non Operating Income -6.01M-5.88M11.25M-12.47M-2.41M4.43M8.96M0.99M5.47M4.69M5.06M
Non Operating Income -0.33M-0.19M-0.19M-0.19M-0.19M4.43M8.96M0.99M5.47M4.69M5.06M
Net income details
EBT -19.16M-16.82M0.73M-25.64M-24.08M-10.13M6.09M-24.82M6.08M-9.69M0.30M
Tax Provisions 0.30M0.19M-0.17M-5.91M0.40M1.50M-2.64M-1.05M1.10M0.61M0.50M
Profit After Tax -19.45M-17.01M0.91M-19.73M-24.44M-11.62M8.74M-23.77M5.02M-10.30M-0.18M
Income from Continuing Operations -19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Consolidated Net Income -19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Income towards Parent Company -19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Net Income towards Common Stockholders -19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Additional items
EPS (Basic) -0.40-0.350.02-0.40-0.49-0.230.17-0.470.10-0.200.00
EPS (Weighted Average and Diluted) -0.40-0.350.02-0.40-0.49-0.230.17-0.470.10-0.200.00
Shares Outstanding (Weighted Average) 47.90M48.09M48.38M48.69M49.44M49.82M50.01M50.02M50.03M50.07M50.23M50.39M
Shares Outstanding (Diluted Average) 0.06M48.89M49.88M50.01M52.81M49.99M51.95M50.29M50.40M
EBITDA -12.02M-10.24M-14.04M-0.57M-23.54M-10.67M11.98M-26.36M5.70M-3.82M-3.57M
Interest Expenses 1.25M1.27M1.32M1.31M3.24M4.28M4.29M7.04M3.02M3.04M3.04M
Tax Rate 23.05%4.23%18.08%